Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
Abbott Laboratories (ABT)
Market Closed
17 Jul, 20:00
NYSE
All
(14)
DE
(6)
AT
(1)
CH
(1)
CL
(1)
IT
(1)
MX
(1)
GB
(2)
US
(1)
NYSE
Primary
LSE
XSTU
XFRA
XMUN
XETRA
XHAN
XWBO
XDUS
SIX
XMEX
XSGO
XMIL
CBOE
$
100.
68
+1.85
+1.8719%
$
154.96B
Market Cap
36.49
P/E Ratio
0.28%
Div Yield
19.91M
Volume
4.44
Eps
$
98.83
Previous Close
Investors:
TJD
DI
MSH
TMB
LC
+903
Watching
Watch
Add Transaction
Day Range
99.47
102.13
Year Range
81.97
137.49
Want to track
ABT
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
News
Historical Data
Investors
Abbott Laboratories (ABT) Statistics
Valuation metrics
Market Cap
154.96B
Enterprise value
202.59B
Trailing P/E (ttm)
27.96
Forward P/E
15.29
PEG ratio
-0.46
Price/Sales (ttm)
3.89
Price/Book (mrq)
3.38
Enterprise Value/Revenue
4.35
Enterprise Value/EBITDA
20.38
Overview
Shares outstanding
1.74B
Float
1.73B
Shares short
23.83M
% Held by insiders
0.01%
% Held by institutions
0.82%
Average volume (10 days)
15.35M
Average volume (90 days)
13.63M
Price summary
52-Week low
81.97
52-Week high
137.49
Beta
0.78
50-Day moving average
91.74
200-Day moving average
104.01
Dividends and splits
Forward annual dividend rate
2.52
Forward annual dividend yield
0.0273%
Trailing annual dividend rate
2.48
Trailing annual dividend yield
0.0246%
5-Year annual dividend yield
1.77%
Payout ratio
0.67
Dividend Date
15 May 2026
Ex-Dividend Date
15 Apr 2026
Last split factor
10,000:4,798
Last split Date
2 Jan 2013
Financials
Fiscal year
Fiscal year ends
31 Dec 2025
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.14%
Operating margin
0.18%
Operational effectiveness
Return on assets
0.05%
Return on equity
0.11%
Income Statement
Revenue (ttm)
45.13B
Revenue per share (ttm)
25.84
Quarterly revenue growth (yoy)
0.08%
Gross profit (ttm)
25.49B
EBITDA
12.03B
Net income to common (ttm)
6.25B
Diluted EPS (ttm)
3.59
Quarterly earnings growth (yoy)
-0.19%
Balance Sheet
Total cash (mrq)
8.94B
Total cash per share (mrq)
4.18
Total debt (mrq)
14.14B
Total Debt/Equity (mrq)
0.65
Current ratio (mrq)
1.39%
Book value per share (mrq)
30.17
Cash Flow
Cash flow statement
10.8B
Levered free cash flow (LFCF)
13.77B